These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33622595)

  • 1. Oncological outcomes of robotic-assisted total mesorectal excision after neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer.
    Chen PJ; Su WC; Chang TK; Chen YC; Li CC; Yin TC; Tsai HL; Ma CJ; Huang CW; Wang JY
    Asian J Surg; 2021 Jul; 44(7):957-963. PubMed ID: 33622595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of long-term efficacy between watch and wait strategy and total mesorectal excision in locally advanced rectal cancer patients with clinical complete response after neoadjuvant therapy].
    Wang XH; Zhou CJ; Zhang S; Wang QX; Xiao WW; Ding PR; Chen G; Pan ZZ; Zeng ZF; Gao YH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):266-273. PubMed ID: 32192306
    [No Abstract]   [Full Text] [Related]  

  • 3. Robotic-assisted total mesorectal excision with the single-docking technique for patients with rectal cancer.
    Huang CW; Tsai HL; Yeh YS; Su WC; Huang MY; Huang CM; Chang YT; Wang JY
    BMC Surg; 2017 Dec; 17(1):126. PubMed ID: 29208050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An observational study of patho-oncological outcomes of various surgical methods in total mesorectal excision for rectal cancer: a single center analysis.
    Chen YT; Huang CW; Ma CJ; Tsai HL; Yeh YS; Su WC; Chai CY; Wang JY
    BMC Surg; 2020 Feb; 20(1):23. PubMed ID: 32013990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time interval between the completion of radiotherapy and robotic-assisted surgery among patients with stage I-III rectal cancer undergoing preoperative chemoradiotherapy.
    Huang CW; Su WC; Yin TC; Chen PJ; Chang TK; Chen YC; Li CC; Hsieh YC; Tsai HL; Wang JY
    PLoS One; 2020; 15(10):e0240742. PubMed ID: 33064768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term oncological outcomes of robotic versus laparoscopic total mesorectal excision of mid-low rectal cancer following neoadjuvant chemoradiation therapy.
    Lim DR; Bae SU; Hur H; Min BS; Baik SH; Lee KY; Kim NK
    Surg Endosc; 2017 Apr; 31(4):1728-1737. PubMed ID: 27631313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
    Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
    Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local excision versus total mesorectal excision for rectal cancer patients with clinical complete or near-complete response after neoadjuvant chemoradiotherapy.
    Jin L; Zheng K; Hong Y; Yu E; Hao L; Zhang W
    Int J Colorectal Dis; 2024 Oct; 39(1):157. PubMed ID: 39379611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgery with versus without preoperative concurrent chemoradiotherapy for mid/low rectal cancer: an interim analysis of a prospective, randomized trial.
    Fan WH; Wang FL; Lu ZH; Pan ZZ; Li LR; Gao YH; Chen G; Wu XJ; Ding PR; Zeng ZF; Wan DS
    Chin J Cancer; 2015 Jun; 34(9):394-403. PubMed ID: 26111932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologic and survival outcomes in elderly patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy and total mesorectal excision.
    He F; Chen M; Xiao WW; Zhang Q; Liu Y; Zheng J; Wan XB; Gao YH
    Jpn J Clin Oncol; 2021 Aug; 51(9):1391-1399. PubMed ID: 34155513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.
    Kulu Y; Tarantino I; Billeter AT; Diener MK; Schmidt T; Büchler MW; Ulrich A
    Ann Surg Oncol; 2016 Jan; 23(1):106-13. PubMed ID: 26305025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 14. Robotic beyond total mesorectal excision for locally advanced rectal cancers: Perioperative and oncological outcomes from a multicentre case series.
    Khan JS; Piozzi GN; Rouanet P; Saklani A; Ozben V; Neary P; Coyne P; Kim SH; Garcia-Aguilar J
    Eur J Surg Oncol; 2024 Jun; 50(6):108308. PubMed ID: 38583214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for local recurrence in patients with rectal cancer submitted to neoadjuvant chemoradiotherapy and total mesorectal excision.
    Nahas CSR; Nahas SC; Marques CFS; Ribeiro Junior U; Bustamante-Lopez L; Cotti GC; Imperiale AR; Pinto RA; Cecconello I
    Clinics (Sao Paulo); 2024; 79():100464. PubMed ID: 39126876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total mesorectal excision with or without preoperative chemoradiotherapy for resectable mid/low rectal cancer: a long-term analysis of a prospective, single-center, randomized trial.
    Wang F; Fan W; Peng J; Lu Z; Pan Z; Li L; Gao Y; Li H; Chen G; Wu X; Ding P; Zeng Z; Wan D
    Cancer Commun (Lond); 2018 Dec; 38(1):73. PubMed ID: 30572939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer.
    Chen JN; Liu Z; Wang ZJ; Mei SW; Shen HY; Li J; Pei W; Wang Z; Wang XS; Yu J; Liu Q
    World J Gastroenterol; 2020 Jun; 26(21):2877-2888. PubMed ID: 32550762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Short-term efficacy of robotic-assisted total mesorectal excision with and without lateral lymph node dissection for mid-low advanced rectal cancer: a propensity score matching analysis].
    Shi FY; Zhang L; Qin Q; Jin X; Hu CH; Yu TY; Ma L; Wang GH; Wu H; Xia P; Sun XJ; She JJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Apr; 23(4):370-376. PubMed ID: 32306605
    [No Abstract]   [Full Text] [Related]  

  • 19. Robotic versus laparoscopic sphincter-saving total mesorectal excision for mid or low rectal cancer in male patients after neoadjuvant chemoradiation therapy: comparison of long-term outcomes.
    Asoglu O; Tokmak H; Bakir B; Aliyev V; Saglam S; Iscan Y; Bademler S; Meric S
    J Robot Surg; 2020 Jun; 14(3):393-399. PubMed ID: 31313071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local excision after neoadjuvant chemoradiotherapy versus total mesorectal excision: a case-matched study in 110 selected high-risk patients with rectal cancer.
    Calmels M; Collard MK; Cazelles A; Frontali A; Maggiori L; Panis Y
    Colorectal Dis; 2020 Dec; 22(12):1999-2007. PubMed ID: 32813899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.